Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 28% ± 10% | |
microglial cell | 6 studies | 22% ± 6% | |
mucosal invariant T cell | 5 studies | 21% ± 3% | |
epithelial cell | 4 studies | 23% ± 5% | |
non-classical monocyte | 3 studies | 26% ± 9% | |
GABAergic neuron | 3 studies | 37% ± 10% | |
glutamatergic neuron | 3 studies | 36% ± 16% | |
macrophage | 3 studies | 23% ± 7% | |
group 3 innate lymphoid cell | 3 studies | 25% ± 4% | |
interneuron | 3 studies | 31% ± 19% | |
neuron | 3 studies | 26% ± 9% | |
astrocyte | 3 studies | 19% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 3842.43 | 1808 / 1809 | 100% | 57.73 | 471 / 472 |
lung | 100% | 3932.64 | 577 / 578 | 100% | 42.31 | 1153 / 1155 |
esophagus | 100% | 3413.36 | 1445 / 1445 | 99% | 39.32 | 182 / 183 |
ovary | 100% | 5784.53 | 180 / 180 | 99% | 35.41 | 427 / 430 |
thymus | 100% | 5330.40 | 652 / 653 | 99% | 51.18 | 601 / 605 |
brain | 99% | 4265.74 | 2619 / 2642 | 100% | 48.05 | 705 / 705 |
liver | 100% | 2318.73 | 225 / 226 | 99% | 34.42 | 402 / 406 |
breast | 100% | 3109.49 | 459 / 459 | 98% | 31.58 | 1101 / 1118 |
stomach | 100% | 4023.55 | 359 / 359 | 98% | 37.48 | 280 / 286 |
uterus | 100% | 4587.37 | 170 / 170 | 97% | 38.72 | 447 / 459 |
pancreas | 100% | 3834.45 | 328 / 328 | 97% | 42.88 | 173 / 178 |
intestine | 100% | 4392.26 | 966 / 966 | 97% | 32.59 | 509 / 527 |
kidney | 100% | 3948.29 | 89 / 89 | 95% | 33.23 | 859 / 901 |
adrenal gland | 100% | 5064.35 | 258 / 258 | 92% | 54.70 | 211 / 230 |
bladder | 100% | 3169.90 | 21 / 21 | 79% | 21.78 | 399 / 504 |
prostate | 99% | 2913.31 | 243 / 245 | 71% | 10.07 | 357 / 502 |
adipose | 100% | 3561.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 52.22 | 29 / 29 |
spleen | 100% | 4491.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 41.03 | 45 / 45 |
blood vessel | 100% | 3614.39 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 5208.67 | 859 / 861 | 0% | 0 | 0 / 0 |
muscle | 100% | 2765.75 | 799 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 46.05 | 79 / 80 |
peripheral blood | 99% | 4496.96 | 916 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016310 | Biological process | phosphorylation |
GO_0006672 | Biological process | ceramide metabolic process |
GO_0006688 | Biological process | glycosphingolipid biosynthetic process |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005524 | Molecular function | ATP binding |
GO_0102773 | Molecular function | dihydroceramide kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0001729 | Molecular function | ceramide kinase activity |
Gene name | CERK |
Protein name | Ceramide kinase (cDNA: FLJ23239 fis, clone COL01248) CERK protein Ceramide kinase Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4) |
Synonyms | KIAA1646 |
Description | FUNCTION: Catalyzes specifically the phosphorylation of ceramide to form ceramide 1-phosphate . Acts efficiently on natural and analog ceramides (C6, C8, C16 ceramides, and C8-dihydroceramide), to a lesser extent on C2-ceramide and C6-dihydroceramide, but not on other lipids, such as various sphingosines . Shows a greater preference for D-erythro isomer of ceramides . Binds phosphoinositides . . |
Accessions | F8WFD8 Q9H5N7 Q8TCT0 Q6I9Z0 ENST00000216264.13 [Q8TCT0-1] ENST00000443629.5 |